• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant.

作者信息

Seeger W, Thede C, Günther A, Grube C

机构信息

Department of Internal Medicine, Justus-Liebig-University Giessen, F.R.G.

出版信息

Biochim Biophys Acta. 1991 Jan 4;1081(1):45-52. doi: 10.1016/0005-2760(91)90248-g.

DOI:10.1016/0005-2760(91)90248-g
PMID:1991155
Abstract

Surfactant alterations due to protein leakage are implicated in the pathogenesis of the adult respiratory distress syndrome. In the present study, surface properties of a palmitic acid containing phospholipid mixture (DPPC: PG: PA/68.5:22.5:9) supplemented with 2% recombinant human surfactant apoprotein C (PLM-Crec) were compared to those of the lipids alone (PLM) and to those of calf lung surfactant extract (CLSE). Experiments were performed in a Wilhelmy balance and in a pulsating bubble surfactometer. Adsorption facilities and dynamic surface tension-lowering properties of the surfactants alone, their sensitivity to the inhibitory effect of fibrinogen (fbg), and their capacity to restore surface properties of fbg-inhibited CLSE were investigated. PLM revealed limited surface activity, was very sensitive to inhibition by fbg and had moderate effect on the surface properties of fbg-inhibited CLSE. In contrast, PLM-Crec and CLSE revealed similar excellent adsorption kinetics and dynamic surface tension lowering properties. Higher percentage of SP-C within the synthetic mixture (up to 10%) or additional admixture of human purified or recombinant SP-A (up to 10%) did not further improve these surface properties. However, PLM-Crec was markedly more sensitive to inactivation by fbg than CLSE. The surface activity of fbg-inhibited CLSE was fully restored by additional admixture of CLSE or PLM-Crec in both the Wilhelmy and the bubble system, with slight superiority of the natural surfactant extract. We conclude that the surface properties of PLM-Crec are clearly superior to those of the apoprotein-free lipid mixture and are similar to those of the natural surfactant extract CLSE. PLM-Crec is markedly more sensitive to inhibition by fibrinogen than CLSE, but possesses nearly equivalent efficacy in restoring the surface properties of fbg-inhibited CLSE as compared to the natural material.

摘要

相似文献

1
Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant.
Biochim Biophys Acta. 1991 Jan 4;1081(1):45-52. doi: 10.1016/0005-2760(91)90248-g.
2
Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants.基于表面活性蛋白C与表面活性蛋白B的表面活性剂对纤维蛋白原抑制的差异敏感性。
Am J Physiol. 1992 Mar;262(3 Pt 1):L286-91. doi: 10.1152/ajplung.1992.262.3.L286.
3
Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.血浆蛋白对表面活性剂的抑制作用:各种表面活性剂制剂的差异敏感性。
Eur Respir J. 1993 Jul;6(7):971-7.
4
Pulmonary lung surfactant synthetic peptide concentration-dependent modulation of DPPC and POPG acyl chain order in a DPPC:POPG:palmitic acid lipid mixture.肺表面活性物质合成肽对二棕榈酰磷脂酰胆碱(DPPC):磷脂酰甘油(POPG):棕榈酸脂质混合物中DPPC和POPG酰链顺序的浓度依赖性调节
Chem Phys Lipids. 1994 May 6;71(1):47-59. doi: 10.1016/0009-3084(94)02316-6.
5
Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity.肺表面活性物质中双棕榈酰磷脂酰胆碱的含量:对表面活性的影响
Pediatr Res. 1996 May;39(5):805-11. doi: 10.1203/00006450-199605000-00010.
6
Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity.
Am J Respir Cell Mol Biol. 1993 Aug;9(2):213-20. doi: 10.1165/ajrcmb/9.2.213.
7
Multiple mechanisms of lung surfactant inhibition.肺表面活性物质抑制的多种机制。
Pediatr Res. 1999 Jul;46(1):85-93. doi: 10.1203/00006450-199907000-00015.
8
Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.一种抗磷脂酶的合成表面活性剂在大鼠肺中的活性及抗抑制性
Am J Respir Cell Mol Biol. 2007 Oct;37(4):387-94. doi: 10.1165/rcmb.2006-0434OC. Epub 2007 Jun 7.
9
Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine.一种含有二棕榈酰磷脂酰胆碱的抗磷脂酶膦脂类似物的合成肺表面活性剂的表面活性。
Am J Physiol Lung Cell Mol Physiol. 2003 Sep;285(3):L550-9. doi: 10.1152/ajplung.00346.2002.
10
Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.疏水载脂蛋白作为临床外源性表面活性剂成分的重要性。
Am Rev Respir Dis. 1992 Jan;145(1):24-30. doi: 10.1164/ajrccm/145.1.24.

引用本文的文献

1
Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.急性呼吸窘迫综合征患者经表面活性剂治疗后肺泡表面活性有所改善,但未恢复正常:中性脂质的假定作用
Thorax. 2007 Jul;62(7):588-94. doi: 10.1136/thx.2006.062398. Epub 2007 Feb 7.
2
Surfactant therapy for meconium aspiration syndrome: current status.胎粪吸入综合征的表面活性剂治疗:现状
Drugs. 2005;65(18):2569-91. doi: 10.2165/00003495-200565180-00003.
3
Surfactant alteration and replacement in acute respiratory distress syndrome.
急性呼吸窘迫综合征中的表面活性剂改变与替代
Respir Res. 2001;2(6):353-64. doi: 10.1186/rr86. Epub 2001 Oct 12.
4
Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.肺泡表面活性物质与成人呼吸窘迫综合征。发病机制作用及治疗前景。
Clin Investig. 1993 Mar;71(3):177-90. doi: 10.1007/BF00180100.